Pulmonary vasoregulation by endothelin in conscious dogs after left lung transplantation

Journal of Applied Physiology

Volumn 88, Issue 1, 2000, Pages 210-218

  Doi, Shouzaburoh ^a   Smedira, Nicholas ^a   Murray, Paul A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Endothelin receptor antagonists; Hypoxic pulmonary vasoconstriction; Pulmonary vascular pressure flow relationship

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOTRANSPLANTATION; CONTROLLED STUDY; DOG; HYPOXIA; HYPOXIC LUNG VASOCONSTRICTION; LUNG BLOOD FLOW; LUNG CIRCULATION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033985112     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2000.88.1.210     Document Type: Article

References (54)

1. Aarnio, P., P. Tukiainen, E. Taskinen, A. Harjula, and F. Fyhrquist. Endothelin in bronchoalveolar lavage fluid is increased in lung-transplanted patients. Scand. J. Thorac. Cardiovasc. Surg. 30: 113-116, 1996.
2. Cacoub, P., R. Dorent, G. Maistre, P. Nataf, A. Carayon, J. C. Piette, P. Godeau, C. Cabrol, and I. Gandjbakhch. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am. J. Cardiol. 71: 448-450, 1993.
3. Cacoub, P., R. Dorent, P. Nataf, and A. Carayon. Endothelin-1 in pulmonary hypertension. N. Engl. J. Med. 329: 1967-1968, 1993.
4. Chen, B. B., D. P. Nyhan, D. M. Fehr, and P. A. Murray. Halothane anesthesia abolishes pulmonary vascular responses to neural antagonists. Am. J. Physiol. Heart Circ. Physiol. 262: H117-H122, 1992.
5. Chen, S. J., Y. F. Chen, Q. C. Meng, J. Durand, V. S. Dicarlo, and S. Oparil. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79: 2122-2131, 1995.
6. Chen, S. J., Y. F. Chen, T. J. Opgenorth, J. L. Wessale, Q. C. Meng, J. Durand, V. S. Dicarlo, and S. Oparil. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats. J. Cardiovasc. Pharmacol. 29: 713-725, 1997.
7. B-receptors mediating constriction and relaxation? J. Cardiovasc. Pharmacol 26: S262-S264, 1995.
8. Cody, R. J., G. J. Haas, P. F. Binkley, Q. Capers, and R. Kelley. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85: 504-509, 1992.
9. Desai, P. M., K. Nishiwaki, R. S. Stuart, D. P. Nyhan, and P. A. Murray. Humoral pulmonary vasoregulation in conscious dogs after left lung autotransplantation. J. Appl. Physiol. 76: 902-908, 1994.
10. Douglas, S. A., L. M. Vickery-Clark, and E. H. Ohlstein. Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123. Br. J. Pharmacol. 108:418-421, 1993.
11. Flavahan, N. A., T. D. Aleskowitch, and P. A. Murray. Endothelial and vascular smooth muscle responses are altered after left lung autotransplantation. Am. J. Physiol. Heart Circ. Physiol. 266: H2026-H2032, 1994.
12. Franco-Cereceda, A., and P. Holm. Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension? J. Cardiovasc. Pharmacol. 31: S447-S452, 1998.
13. Frank, D. U., S. M. Lowson, C. M. Roos, and G. F. Rich. Endotoxin blocks hypoxic pulmonary vasoconstriction in isolated rat lungs. J. Appl. Physiol. 81: 1316-1322, 1996.
14. Graham, R., C. Skoog, W. Macedo, J. Carter, L. Oppenheimer, J. Rabson, and H. S. Goldberg. Dopamine, dobutamine, and phentolamine effects on pulmonary vascular mechanics. J. Appl. Physiol. 54: 1277-1283, 1983.
15. Hill, N. S., R. R. Warburton, L. Pietras, and J. R. Klinger. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats. J. Appl. Physiol. 83: 1209-1215, 1997.
16. Holm, P., J. Liska, M. Clozel, and A. Franco-Cereceda. The endothelin antagonist bosentan: hemodynamic effects during normoxia and hypoxic pulmonary hypertension in pigs. J. Thorac. Cardiovasc. Surg. 112: 890-897, 1996.
17. A receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo. Cardiovasc. Res. 37: 765-771, 1998.
18. Lennon, P. F., and P. A. Murray. Attenuated hypoxic pulmonary vasoconstriction during isoflurane anesthesia is abolished by cyclooxygenase inhibition. Anesthesiology 84: 404-414, 1996.
19. Liu, S., D. E. Crawley, P. J. Barnes, and T. W. Evans. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143: 32-37, 1991.
20. Lodato, R. F., J. R. Michael, and P. A. Murray. Absence of neural modulation of hypoxic pulmonary vasoconstriction in conscious dogs. J. Appl. Physiol. 65: 1481-1487, 1988.
21. B receptor-mediated contraction in human pulmonary resistance arteries. Br. J. Pharmacol. 119: 1125-1130, 1996.
22. McDermott, C. D., H. Shennib, and A. Giaid. Immunohistochemical localization of endothelin-1 and endothelin-converting enzyme-1 in rat lung allografts. J. Cardiovasc. Pharmacol. 31: S27-S30, 1998.
23. Mentzer, S. J., J. J. Reilly, M. DeCamp, D. J. Sugarbaker, and D. V. Faller. Potential mechanism of vasomotor dysregulation after lung transplantation for primary pulmonary hypertension. J. Heart Lung Transplant. 14: 387-393, 1995.
24. Mitaka, C., Y. Hirata, K. Yokoyama, T. Nagura, Y. Tsunoda, and K. Amaha. Pathologic role of endothelin-1 in septic shock. J. Cardiovasc. Pharmacol. 31: S233-S235, 1998.
25. Murray, P. A., D. M. Fehr, B. B. Chen, P. Rock, J. W. Esther, P. M. Desai, and D. P. Nyhan. Differential effects of general anesthesia on cGMP-mediated pulmonary vasodilation. J. Appl. Physiol. 73: 721-727, 1992.
26. Murray, P. A., R. S. Stuart, C. D. Fraser, Jr., D. M. Fehr, B. B. Chen, P. Rock, P. M. Desai, and D. P. Nyhan. Acute and chronic pulmonary vasoconstriction after left lung autotransplantation in conscious dogs. J. Appl. Physiol. 73: 603-609, 1992.
27. Nakayama, M., and P. A. Murray. Ketamine preserves and propofol potentiates hypoxic pulmonary vasoconstriction compared with the conscious state in chronically instrumented dogs. Anesthesiology 91: 760-771, 1999.
28. ω-nitro-L-arginine and the pulmonary vascular pressure-flow relationship in conscious dogs. Am. J. Physiol. Heart Circ. Physiol. 262: H1331-H1337, 1992.
29. 1-adrenoreceptor activity in conscious dogs after left lung autotransplantation. J. Appl. Physiol. 74: 733-741, 1993.
30. Nishiwaki, K., D. P. Nyhan, R. S. Stuart, P. Rock, P. M. Desai, W. P. Peterson, and P. A. Murray. Abnormal responses to pulmonary vasodilators in conscious dogs after left lung autotransplantation. Am. J. Physiol. Heart Circ. Physiol. 264: H917-H925, 1993.
31. Nishiwaki, K., P. Rock, R. S. Stuart, D. P. Nyhan, W. P. Peterson, and P. A. Murray. Pulmonary vascular β-adrenoreceptor activity in conscious dogs after left lung autotransplantation. J. Appl. Physiol. 76: 256-263, 1993.
32. Nyhan, D. P., B. B. Chen, D. M. Fehr, P. Rock, and P. A. Murray. Anesthesia alters pulmonary vasoregulation by angiotensin II and captopril. J. Appl. Physiol. 72: 636-642, 1992.
33. Oparil, S., S. J. Chen, Q. C. Meng, T. S. Elton, M. Yano, and Y. F. Chen. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am. J. Physiol. Lung Cell. Mol. Physiol. 268: L95-L100, 1995.
34. Ricagna, F., V. M. Miller, H. D. Tazelaar, and C. G. McGregor. Endothelin-1 and cell proliferation in lung organ cultures. Implications for lung allografts. Transplantation 62: 1492-1498, 1996.
35. Robin, E. D., J. Theodore, C. M. Burke, S. N. Oesterle, M. B. Fowler, S. W. Jamieson, J. C. Baldwin, A. J. Morris, S. A. Hunt, A. Vankessel, E. B. Stinson, and N. E. Shumway. Hypoxic pulmonary vasoconstriction persists in the human transplanted lung. Clin. Sci. (Colch.) 72: 283-287, 1987.
36. Schersten, H., T. Hedner, C. G. McGregor, V. M. Miller, G. Martensson, G. C. Riise, and F. N. Nilsson. Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts. J. Thorac. Cardiovasc. Surg. 111: 253-258, 1996.
37. Seki, S., N. A. Flavahan, N. G. Smedira, and P. A. Murray. Superoxide anion scavengers restore nitric oxide-mediated pulmonary vasodilation after lung transplantation. Am. J. Physiol. Heart Circ. Physiol. 276: H42-H46, 1999.
38. Seki, S., K. Sato, N. G. Smedira, and P. A. Murray. Effects of volatile anesthetics on pulmonary vasodilator response to ATP-sensitive potassium channel activation after left lung autotransplantation (Abstract). Anesthesiology 85: A554, 1996
39. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89: 1203-1208, 1994.
40. Shennib, H., A. G. Lee, J. Q. Kuang, M. Yanagisawa, E. H. Ohlstein, and A. Giaid. Efficacy of administering an endothelin-receptor antagonist (SB209670) in ameliorating ischemia-reperfusion injury in lung allografts. Am. J. Respir. Crit. Care Med. 157: 1975-1981, 1998.
41. Shennib, H., C. Serrick, D. Saleh, R. Adoumie, D. J. Stewart, and A. Giaid. Alterations in bronchoalveolar lavage and plasma endothelin-1 levels early after lung transplantation. Transplantation 59: 994-998, 1995.
42. Shennib, H., C. Serrick, D. Saleh, A. Reis, D. J. Stewart, and A. Giaid. Plasma endothelin-1 levels in human lung transplant recipients. J. Cardiovasc. Pharmacol. 26: S516-S518, 1995.
43. B receptors mediating venous smooth muscle contraction. Biochem. Biophys. Res. Commun. 200: 627-633, 1994.
44. Takeda, S., Y. Sawa, M. Minami, Y. Kaneda, Y. Fujii, R. Shirakura, M. Yanagisawa, and H. Matsuda. Experimental bronchiolitis obliterans induced by in vivo HVJ-liposome-mediated endothelin-1 gene transfer. Ann. Thorac. Surg. 63: 1562-1567, 1997.
45. Takeoka, M., T. Ishizaki, A. Sakai, S. W. Chang, K. Shigemori, T. Higashi, and G. Ueda. Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol. Scand. 155: 53-60, 1995.
46. Uhlig, S., A. N. von Bethmann, R. L. Featherstone, and A. Wendel. Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung. Am. J. Respir. Crit. Care Med. 152: 1449-1460, 1995.
47. Wanacek, M., A. Rudehill, A. Hemsen, J. M. Lundberg, and E. Weitzberg. The endothelin antagonist, bosentan, in combination with the cylcooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxic shock. Crit. Care Med. 25: 848-857, 1997.
48. Wang, Y., Y. Coe, O. Toyoda, and F. Coceani. Involvement of endothelin-1 in hypoxic pulmonary vasoconstriction in the lamb. J. Physiol. (Lond.) 482: 421-434, 1995.
49. Warner, T. D., G. H. Allcock, R. Corder, and J. R. Vane. Use of the endothelin antagonists BQ-123 and PD142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br. J. Pharmacol. 110: 777-782, 1993.
50. Wilkinson, L. Systat: The System for Statistics. Evanston, IL: Systat, 1990.
51. Willette, R. N., E. H. Ohlstein, M. P. Mitchell, C. F. Sauermelch, G. R. Beck, M. A. Luttmann, and D. W. Hay. Nonpeptide endothelin receptor antagonists. VIII: attenuation of acute hypoxia-induced pulmonary hypertension in the dog. J. Pharmacol. Exp. Ther. 280: 695-701, 1997.
52. Wong, J., P. A. Vanderford, J. W. Winters, R. Chang, S. J. Soifer, and J. R. Fineman. Endothelin-1 does not mediate acute hypoxic pulmonary vasoconstriction in the intact newborn lamb. J. Cardiovasc. Pharmacol. 22: S262-S266, 1993.
53. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
54. Yoshida, K., N. A. Flavahan, M. Horibe, N. G. Smedira, and P. A. Murray. Endothelial defect mediates attenuated pulmonary vasorelaxant response to isoproterenol after left lung transplantation. Am. J. Physiol. Heart Circ. Physiol. 276: H159-H166, 1999.